858 related articles for article (PubMed ID: 28604751)
1. Melanocytic nevi and melanoma: unraveling a complex relationship.
Damsky WE; Bosenberg M
Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
[TBL] [Abstract][Full Text] [Related]
2. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
[TBL] [Abstract][Full Text] [Related]
3. Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.
Tschandl P; Berghoff AS; Preusser M; Pammer J; Pehamberger H; Kittler H
Br J Dermatol; 2016 Feb; 174(2):364-70. PubMed ID: 26613644
[TBL] [Abstract][Full Text] [Related]
4. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
[TBL] [Abstract][Full Text] [Related]
5. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
6. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.
Yeh I; von Deimling A; Bastian BC
J Natl Cancer Inst; 2013 Jun; 105(12):917-9. PubMed ID: 23690527
[TBL] [Abstract][Full Text] [Related]
7. BRAF
McNeal AS; Belote RL; Zeng H; Urquijo M; Barker K; Torres R; Curtin M; Shain AH; Andtbacka RH; Holmen S; Lum DH; McCalmont TH; VanBrocklin MW; Grossman D; Wei ML; Lang UE; Judson-Torres RL
Elife; 2021 Nov; 10():. PubMed ID: 34812139
[TBL] [Abstract][Full Text] [Related]
8. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
Turner DJ; Zirvi MA; Barany F; Elenitsas R; Seykora J
J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117
[TBL] [Abstract][Full Text] [Related]
9. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.
Ruiz-Vega R; Chen CF; Razzak E; Vasudeva P; Krasieva TB; Shiu J; Caldwell MG; Yan H; Lowengrub J; Ganesan AK; Lander AD
Elife; 2020 Oct; 9():. PubMed ID: 33047672
[TBL] [Abstract][Full Text] [Related]
11. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
[TBL] [Abstract][Full Text] [Related]
12. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
Dadzie OE; Yang S; Emley A; Keady M; Bhawan J; Mahalingam M
Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
14. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
15. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary melanocytic nevus - A case report with a mutation analysis of common driver oncogenes.
Tanaka M; Matsumura M; Okudela K; Mitsui H; Tateishi Y; Umeda S; Suzuki T; Koike C; Kataoka T; Kawano N; Kojima Y; Osawa H; Ohashi K
Pathol Int; 2019 Nov; 69(11):667-671. PubMed ID: 31556191
[TBL] [Abstract][Full Text] [Related]
17. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
Dong J; Phelps RG; Qiao R; Yao S; Benard O; Ronai Z; Aaronson SA
Cancer Res; 2003 Jul; 63(14):3883-5. PubMed ID: 12873977
[TBL] [Abstract][Full Text] [Related]
18. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade.
Mauzo SH; Tetzlaff MT; Nelson K; Amaria R; Patel S; Aung PP; Nagarajan P; Torres-Cabala CA; Diab A; Prieto VG; Curry JL
Int J Dermatol; 2019 Sep; 58(9):1045-1052. PubMed ID: 29152725
[TBL] [Abstract][Full Text] [Related]
19. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.
Mudaliar K; Tetzlaff MT; Duvic M; Ciurea A; Hymes S; Milton DR; Tsai KY; Prieto VG; Torres-Cabala CA; Curry JL
Hum Pathol; 2016 Apr; 50():79-89. PubMed ID: 26997441
[TBL] [Abstract][Full Text] [Related]
20. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
Santucci M; Urso C; Giannini A; Bondi R
Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]